Skip to Main Content

Paper Details

Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity.
Cell Syst
9
2022
Author NameAffiliation
Sai ZhangStanford University School of Medicine, USA VA Palo Alto Epidemiology Research and Information Center for Genomics, USA Center for Genomics and Personalized Medicine, USA Stanford Cardiovascular Institute
Jonathan D CooperSheffield Institute for Translational Neuroscience, University of Sheffield
Annika K WeimerStanford University School of Medicine, USA Center for Genomics and Personalized Medicine
Simone FuriniDepartment of Medical Biotechnologies, University of Siena
Alessandra RenieriDepartment of Medical Biotechnologies, University of Siena, Azienda Ospedaliero-Universitaria Senese
John Kenneth BaillieRoslin Institute, University of Edinburgh, Institute of Genetics and Molecular Medicine, Western General Hospital, Royal Infirmary of Edinburgh
Mark M DavisInstitute for Immunity, Stanford University School of Medicine, USA Howard Hughes Medical Institute
Philip S TsaoVA Palo Alto Epidemiology Research and Information Center for Genomics, USA Stanford Cardiovascular Institute, Stanford University School of Medicine
Philip S TsaoVA Palo Alto Epidemiology Research and Information Center for Genomics, USA Stanford Cardiovascular Institute, Stanford University School of Medicine
Michael SnyderStanford University School of Medicine, USA Center for Genomics and Personalized Medicine, USA Stanford Cardiovascular Institute
Michael SnyderStanford University School of Medicine, USA Center for Genomics and Personalized Medicine, USA Stanford Cardiovascular Institute
  • 1 - 11

Datasets